How to Get Started with TRT: Step-by-Step

Most men who eventually start testosterone replacement therapy spend months — sometimes years — recognizing something is off before they take the first concrete step toward evaluation. The gap between “something doesn’t feel right” and “I have a confirmed diagnosis and a protocol” often comes down to not knowing what the process actually looks like. What tests are involved? What happens at the first appointment? How long does it take? What does ongoing monitoring require?

This guide walks through the TRT process from initial suspicion to stable, monitored therapy — step by step, without shortcuts or oversimplification.

Step 1: Recognize the Symptom Pattern

The starting point for TRT is not a prescription — it’s a pattern of symptoms that prompts you to seek evaluation. Low testosterone rarely announces itself clearly. It tends to develop gradually, and individual symptoms are easy to attribute to stress, age, or lifestyle without ever connecting them to a hormonal cause.

The symptoms most consistently associated with testosterone deficiency include:

• Persistent fatigue that doesn’t improve with adequate sleep
• Reduced libido — a global drop in sexual desire, not situational
• Reduced muscle mass and diminished response to training
• Increased body fat, particularly abdominal, despite stable diet
• Low mood, irritability, or reduced motivation that feels different from ordinary stress
• Difficulty concentrating or cognitive flatness
• Reduced morning erections or erectile quality

The pattern matters more than any single symptom. A man who is tired and has low libido and is gaining abdominal fat and isn’t responding to the gym the way he used to — that cluster warrants evaluation. A man who is just tired likely has a dozen possible explanations.

For more detail on how these symptoms present and how to distinguish them from other causes, the overview of symptoms that aren’t always recognized as hormonal is a useful starting point. If fatigue is the primary concern, the article on the connection between persistent fatigue and low testosterone covers that overlap in more detail.

Step 2: Choose a Care Model

Once you’ve decided to seek evaluation, the first practical decision is where to go. Several care models exist for TRT evaluation and management, each with different tradeoffs in cost, access, depth of evaluation, and convenience.

Table 1 — TRT care model comparison. The right choice depends on your clinical situation, insurance status, location, and how complex your hormonal picture may be. For a full cost breakdown by care model, see the TRT cost guide.

Step 3: Get Tested — The Diagnostic Lab Panel

A confirmed diagnosis of hypogonadism requires laboratory evidence — not symptoms alone. Current guidelines from the Endocrine Society and the American Urological Association require two separate morning testosterone measurements below the reference range, combined with clinical symptoms, before treatment is initiated.

Why two tests, and why morning?

Testosterone levels vary throughout the day — peaking in the early morning and declining significantly by afternoon. A single low reading taken at 3 PM may not reflect a true deficiency. Two morning measurements on different days confirm that a low result is consistent and not a transient fluctuation due to illness, stress, or poor sleep. Up to 30% of men who test low on the first draw have a normal result on a second morning draw.

What to expect in a comprehensive panel

The diagnostic labs inform not just whether TRT is appropriate, but which protocol makes sense and what monitoring will need to track. A man with secondary hypogonadism (low LH, low T) may be a candidate for approaches that stimulate natural production rather than replacing testosterone directly. A man with elevated PSA requires urological consultation before therapy is initiated.

Step 4: The Initial Consultation

The first physician appointment covers several things simultaneously: clinical history, physical examination, review of lab results, and — if everything is consistent — discussion of treatment options.

What to expect

A thorough consultation will cover:

• Symptom history: When symptoms started, how they’ve progressed, what else has been tried or ruled out
• Medication review: Several common medications suppress testosterone or raise prolactin — this needs to be identified before attributing low T to primary deficiency
• Relevant medical history: Prior pituitary or testicular conditions, cancer history, cardiovascular history, sleep apnea, fertility goals
• Physical examination: Testicular volume assessment, signs of hypogonadism (reduced body hair, gynecomastia), blood pressure, BMI
• Lab review: The physician interprets results in clinical context — two low testosterone readings with consistent symptoms constitutes a diagnosis under current guidelines

Fertility discussion

If you have any possibility of wanting biological children, this needs to be raised at the first appointment — not after starting TRT. Exogenous testosterone suppresses sperm production in most men, often significantly. Options for fertility preservation include concurrent hCG use, or alternative approaches (clomiphene, anastrozole) that stimulate natural production without suppressing fertility. These decisions are much easier to make before starting than after.

Questions worth asking at your first appointment

• What is causing my low testosterone — primary or secondary hypogonadism?
• Are there reversible contributing factors (obesity, sleep apnea, medications) that should be addressed first?
• What delivery method do you recommend for my situation, and why?
• What will monitoring look like once I start?
• What results are realistic to expect, and on what timeline?

Step 5: Understand Your Delivery Method Options

If a diagnosis is confirmed and TRT is appropriate, the next decision is delivery method. Each option has different pharmacokinetics, cost, administration requirements, and practical tradeoffs. The physician recommends based on your clinical profile and preferences — but knowing the landscape helps you participate in that decision.

Injectable testosterone (cypionate or enanthate) is the most widely used and most cost-effective option. Self-administered subcutaneous injection once or twice weekly is the standard approach for most men starting TRT. It allows precise dosing, easy adjustment, and good laboratory correlation.

For a detailed comparison of delivery methods including cost ranges, level stability, and administration frequency, the complete TRT guide covers all options. For the specific comparison between pellets and injections — two methods that generate the most questions — see the pellets vs. injections guide.

Step 6: Start Therapy and Titrate

TRT protocols typically start conservatively — at the lower end of the therapeutic dosing range — and are adjusted based on lab results and symptom response over the first 3–6 months. This titration phase is important and should not be rushed.

For injectable testosterone, a common starting protocol is 50–100 mg once weekly (subcutaneous or intramuscular), with the first monitoring labs at 6–8 weeks. Dose is adjusted up or down based on mid-cycle testosterone levels, symptoms, hematocrit, and estradiol.

Practical notes for starting injectable TRT:

• Injection technique matters — subcutaneous injection into the abdomen or thigh is simpler and less painful than intramuscular for most men
• Consistent timing reduces level fluctuation — same day each week, same time of day
• Keep a symptom log during the first 8–12 weeks — physician conversations about dose adjustment are much more productive with documented observations
• Don’t adjust dose based on how you feel in week 2 — levels take 4–6 weeks to stabilize at a new dose

Step 7: Ongoing Monitoring — What to Track and When

Monitoring is not optional on TRT. It’s what makes the difference between well-managed therapy and a protocol running on autopilot. Standard monitoring follows current clinical guidelines and includes both laboratory and clinical assessment.

Table 2 — Standard TRT monitoring schedule per Endocrine Society and AUA guidelines. Timing and frequency may vary based on delivery method, dose, and individual risk factors. Hematocrit monitoring is particularly important — see the guide to high hematocrit on TRT for what elevated levels mean.

Lab timing relative to your injection matters. For injectable testosterone, blood is typically drawn at trough (just before the next injection) to measure the lowest level in your cycle, or at mid-cycle to assess the average. Peak draws (1–2 days post-injection) give high readings that don’t reflect typical levels. Your physician will specify when to draw.

Step 8: Know What to Expect — and What to Watch For

The first 3–6 months on TRT involve adjustment — both physiologically and in terms of protocol optimization. Having realistic expectations reduces unnecessary anxiety about the process.

Side effects to watch for and report

• Hematocrit elevation: The most common manageable side effect. Monitored via labs; addressed by dose reduction or therapeutic phlebotomy if hematocrit exceeds safe thresholds
• Elevated estradiol: Can cause water retention, mood changes, or gynecomastia; typically managed by dose adjustment
• Acne: Androgenic effect on skin; usually mild; dose-dependent
• Testicular atrophy: Expected with exogenous testosterone; addressed with hCG if preservation is a priority
• Sleep apnea worsening: TRT can worsen OSA; important to report new or worsening snoring or sleep disruption to your physician

For a comprehensive overview of TRT side effects and how they’re managed, the guide to TRT side effects covers each in clinical detail.

Frequently Asked Questions

How long does it take to get started with TRT from initial appointment to first injection?

The timeline varies by care model. At a men’s health clinic or online platform, the process from initial consultation to first prescription can be as fast as 1–2 weeks — particularly if you complete labs before or alongside the first appointment. At a traditional specialist, the timeline may be 4–8 weeks due to wait times and the requirement for two separate lab draws. The two-draw requirement adds at least a few days to a week regardless of care model.

Can I get tested for low testosterone without a physician referral?

In most U.S. states, direct-to-consumer lab services allow you to order a basic testosterone panel without a physician’s order. This can be useful for preliminary information, but a physician must still evaluate the results, confirm the diagnosis, and prescribe treatment. A direct-to-consumer test that shows low testosterone does not by itself constitute a diagnosis or justify starting therapy.

What if my testosterone is “borderline” — not clearly low, not clearly normal?

Borderline results require additional context. A total testosterone of 310 ng/dL in a symptomatic man with low free testosterone, elevated SHBG, and consistent symptoms warrants a different conversation than the same number in an asymptomatic man. This is one reason why the clinical interpretation matters more than simply comparing a number to a reference range. A physician experienced in hormonal medicine will factor in free testosterone, SHBG, symptom severity, and clinical history before concluding whether treatment is appropriate.

Do I need to make lifestyle changes before starting TRT?

In some cases, yes — particularly when there are reversible contributing factors. Men with significant obesity, untreated sleep apnea, or opioid use that may be suppressing testosterone are often encouraged to address those factors first, since they can meaningfully raise testosterone independently. For men with primary hypogonadism or whose levels remain clearly deficient after lifestyle improvement, TRT is the appropriate next step regardless of lifestyle status.

Will I need TRT for life?

For men with primary hypogonadism, ongoing therapy is typically required. For men with secondary hypogonadism driven by reversible causes (significant obesity, sleep apnea, medication effects), testosterone may recover with appropriate treatment, making long-term TRT potentially unnecessary. This should be explicitly discussed with a physician — particularly for younger men for whom long-term implications are more significant.

Does starting TRT mean I can never stop?

TRT can be discontinued, but it requires medical supervision. Natural testosterone production — which is suppressed while on therapy — recovers over weeks to months after discontinuation. Some physicians use SERMs (clomiphene, enclomiphene) to accelerate recovery of the hypothalamic-pituitary-gonadal axis. Symptoms of low testosterone typically return during the recovery period. Stopping TRT unilaterally without a medical plan is not advisable.

How do I know if TRT is actually working?

A well-structured evaluation includes both subjective (symptom) and objective (lab) measures. Improvement in energy, libido, mood, and body composition — alongside testosterone levels in the mid-normal range on labs — constitutes a positive response. If symptoms haven’t improved meaningfully after 6 months at therapeutic levels, the physician should reassess whether a non-hormonal cause may be contributing. TRT addresses hormonal deficiency; it doesn’t override other causes of fatigue, mood changes, or sexual dysfunction.

What happens at the 3-month lab check?

The 3-month visit is typically the first comprehensive assessment after starting TRT. Labs include testosterone (timed appropriately to your delivery method), free testosterone, estradiol, hematocrit, PSA, and a basic metabolic panel. The physician reviews both lab values and symptom response to determine whether the dose is appropriate, whether any side effects require attention, and whether the protocol is working as intended. Most dose adjustments happen at or shortly after this visit.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715–1744. doi:10.1210/jc.2018-00229
2. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423–432. doi:10.1016/j.juro.2018.03.115
3. Khera M, Broderick GA, Carson CC, et al. Adult-onset hypogonadism. Mayo Clin Proc. 2016;91(7):908–926. doi:10.1016/j.mayocp.2016.04.022
4. Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men (Testosterone Trials). N Engl J Med. 2016;374(7):611–624. doi:10.1056/NEJMoa1506119
5. Lincoff AM, Bhasin S, Flevaris P, et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023;389(2):107–117. doi:10.1056/NEJMoa2215025
6. Wu FC, Tajar A, Beynon JM, et al. Identification of Late-Onset Hypogonadism in Middle-Aged and Elderly Men. N Engl J Med. 2010;363(2):123–135. doi:10.1056/NEJMoa0911101
7. U.S. National Library of Medicine. Hypogonadism. MedlinePlus. medlineplus.gov/ency/article/000390.htm